½ÃÀ庸°í¼­
»óǰÄÚµå
1813284

¼¼°èÀÇ ´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºí ½ÃÀå ¿¹Ãø(-2032³â) : µð¹ÙÀ̽º À¯Çüº°, ÅëÇÕ ¸ðµåº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®

Neuro-Inclusive Wearables Market Forecasts to 2032 - Global Analysis By Device Type, Integration Mode, Technology, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºí ½ÃÀåÀº 2025³â¿¡ 15¾ï ´Þ·¯¸¦ Â÷ÁöÇϰí, ¿¹Ãø ±â°£ µ¿¾È CAGR 16%·Î ¼ºÀåÇÏ¿© 2032³â¿¡´Â 42¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºíÀº ³ú Ȱµ¿, ½ºÆ®·¹½º ¼öÁØ, ½Å°æ ½ÅÈ£¸¦ ¸ð´ÏÅ͸µÇÏ¿© »ç¿ëÀÚÀÇ ÀÎÁö, °¨°¢, ½Å°æÇÐÀû ¿ä±¸¸¦ Áö¿øÇϵµ·Ï ¼³°èµÈ µðÁöÅÐ ±â±âÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¿þ¾î·¯ºí¿¡´Â ³úÆÄ°è(EEG), ¹ÙÀÌ¿À¼¾¼­, ÀΰøÁö´É µîÀÇ ±â¼úÀÌ ÅëÇյǾî ÀÖ¾î ³úÀÇ °Ç°­ »óŸ¦ ½Ç½Ã°£À¸·Î ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿þ¾î·¯ºí ±â±â´Â ÀÚÆóÁõ, ADHD, Á¤½Å °Ç°­ ¹®Á¦ µîÀÇ Áõ»ó¿¡ ´ëÀÀÇÔÀ¸·Î½á Æ÷¿ë¼ºÀ» ³ôÀÌ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºíÀº ÇコÄɾî, À£´Ï½º, º¸Á¶ ±â¼ú ºÐ¾ß¿¡¼­ °³ÀÎ ¸ÂÃãÇü Áö¿øÀ» À§ÇØ »ç¿ëµË´Ï´Ù.

¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é, 10¾ï ¸í ÀÌ»óÀÌ ½Å°æ Àå¾Ö¸¦ ¾Î°í ÀÖÀ¸¸ç, ADHD, ÀÚÆóÁõ, ºÒ¾ÈÁõ µîÀÇ Áõ»óÀ» Áö¿øÇϱâ À§ÇØ ¼³°èµÈ ¿þ¾î·¯ºí ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

³ú-ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ±â¼úÀÇ ¹ßÀü

´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºí ½ÃÀåÀº Á¢±Ù¼º°ú ÀÎÁö Áö¿øÀ» °­È­ÇÏ´Â ³ú-ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º(BCI) ±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀü¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ» ÅëÇØ ½Å°æ ÁúȯÀ» ¾Î°í ÀÖ´Â »ç¶÷µéÀÌ µðÁöÅÐ Ç÷§Æû°ú ¿øÈ°ÇÏ°Ô »óÈ£ÀÛ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾î µ¶¸³¼º°ú »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ½Å°æ ½ÅÈ£ ÇØµ¶°ú ºñħ½ÀÀû ¼¾¼­ÀÇ ºñ¾àÀûÀÎ ¹ßÀü¿¡ ÈûÀÔ¾î BCI ±â¹Ý ¿þ¾î·¯ºíÀº ÇコÄÉ¾î ¹× Áö¿ø ¾ÖÇø®ÄÉÀÌ¼Ç Àü¹Ý¿¡ °ÉÃÄ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´ëÇаú ÇÏÀÌÅ×Å© ±â¾÷ÀÇ ¿¬±¸ Çù·Â È®´ë´Â »ó¾÷È­¸¦ °¡¼ÓÈ­Çϰí, BCI Çõ½ÅÀ» Áß¿äÇÑ ¼ºÀå Ã˸ÅÁ¦·Î¼­ È®°íÈ÷ ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

º¹ÀâÇÑ ±ÔÁ¦ ½ÂÀÎ ÀýÂ÷

´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºí ½ÃÀåÀÇ Áß¿äÇÑ ¾ïÁ¦¿äÀÎÀº ÀÇ·á±â±âÀÇ ±ÔÁ¦ ½ÂÀÎ ÀýÂ÷°¡ º¹ÀâÇÏ´Ù´Â Á¡ÀÔ´Ï´Ù. FDA ¹× EMA¿Í °°Àº ±â°üÀÇ ¾ö°ÝÇÑ ¿ä±¸»çÇ×Àº °³¹ß ±â°£À» ¿¬ÀåÇϰí Á¦Á¶¾÷üÀÇ ÄÄÇöóÀ̾𽺠ºñ¿ëÀ» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾ö°ÝÇÑ ±âÁØÀº ¾ÈÀü¿¡´Â ÇʼöÀûÀÌÁö¸¸, ¼Ò±Ô¸ð Çõ½Å°¡µéÀÇ ½ÃÀå ÁøÀÔÀ» °¡·Î¸·´Â °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áö¿ª¸¶´Ù ½ÂÀÎ ÇÁ·ÎÅäÄÝÀÌ ´Ù¸£´Ù´Â Á¡µµ ¼¼°è »ó¿ëÈ­ Àü·«À» º¹ÀâÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù. ±× °á°ú, ±ä ±ÔÁ¦ °æ·Î°¡ º´¸ñÇö»óÀ¸·Î ÀÛ¿ëÇÏ¿© Á¦Ç° Ãâ½Ã¸¦ Áö¿¬½ÃŰ°í ½ÃÀå È®´ë¸¦ ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ ¼ºÀå

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºíÀÇ À¯¸ÁÇÑ Ã¤¿ë ±âȸ¸¦ âÃâÇÕ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº ÀÓ»ó ȯ°æ ¹Û¿¡¼­ ³ú Ȱµ¿À» ¸ð´ÏÅ͸µÇϰí, ½ºÆ®·¹½º¸¦ °¨ÁöÇϰí, ÀçȰ ÁøÇà »óȲÀ» ÃßÀûÇϱâ À§ÇØ ¿þ¾î·¯ºíÀ» µµÀÔÇÏ´Â °æ¿ì°¡ ´Ã°í ÀÖ½À´Ï´Ù. ½Å°æ°è ÁúȯÀÇ Áõ°¡¿Í ¸ÂÃãÇü Ä¡·áÀÇ Áõ°¡¿¡ ÈûÀÔ¾î ¿ø°Ý ¸ð´ÏÅ͸µÀº º´¿ø ¹æ¹®À» ÁÙÀ̸鼭 ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á Ç÷§Æû°úÀÇ ÅëÇÕÀº ¼ºÀå °¡´É¼ºÀ» ´õ¿í È®´ëÇÒ ¼ö ÀÖ½À´Ï´Ù. µðÁöÅÐ ÇコÄÉ¾î »ýŰ谡 ÁøÈ­ÇÔ¿¡ µû¶ó ½Å°æÇÐÀû Æ÷°ý¼ºÀ» À§ÇØ Á¶Á¤µÈ ¿þ¾î·¯ºíÀº Ä¿³ØÆ¼µå Çコ ¼Ö·ç¼Ç¿¡¼­ Áß½ÉÀûÀÎ ¿ªÇÒÀ» ÇÏ°Ô µÉ °ÍÀÔ´Ï´Ù.

µ¥ÀÌÅÍ º¸¾È°ú ÇÁ¶óÀ̹ö½Ã ¹®Á¦

´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºí ½ÃÀåÀº µ¥ÀÌÅÍ º¸¾È°ú ÇÁ¶óÀ̹ö½Ã º¸È£¿¡ ´ëÇÑ ¿ì·Á°¡ Ä¿Áö¸é¼­ À§Çù¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºíÀº ½Å°æÇÐÀû ¹× »ý¸®Àû ±â¹Ð µ¥ÀÌÅ͸¦ ¼öÁýÇϱ⠶§¹®¿¡ »çÀ̹ö °ø°ÝÀÇ ÁÁÀº Ç¥ÀûÀÌ µÇ°í ÀÖ½À´Ï´Ù. Ä§ÇØ´Â ȯÀÚÀÇ ½Å·Ú¸¦ ¶³¾î¶ß¸± »Ó¸¸ ¾Æ´Ï¶ó GDPR, HIPAA µî µ¥ÀÌÅÍ º¸È£ ±ÔÁ¦¿¡ µû¶ó º¥´õ°¡ ¾ö°ÝÇÑ Ã³¹úÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. µðÁöÅÐ Ãë¾à¼º¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ µµÀÔ¿¡ ´ëÇÑ ¸Á¼³ÀÓÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù. °­·ÂÇÑ ¾Ïȣȭ, À͸íÈ­, ÄÄÇöóÀ̾𽺠ÇÁ·¹ÀÓ¿öÅ©°¡ ¾ø´Ù¸é, º¸¾È À§ÇèÀº ½Å·Ú¸¦ ÈѼÕÇÏ°í ½Å°æÀ» Æ÷°ýÇÏ´Â ¿þ¾î·¯ºíÀÇ Àü ¼¼°èÀûÀÎ º¸±ÞÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

COVID-19 »çÅ´ ´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºí ½ÃÀå¿¡ ÀÌÁßÀ¸·Î ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. Ãʱ⿡´Â °ø±Þ¸ÁÀÇ È¥¶õ°ú ÀÓ»ó½ÃÇè Áö¿¬À¸·Î Á¦Ç° Ãâ½Ã°¡ Áö¿¬µÇ¾ú½À´Ï´Ù. ÇÏÁö¸¸, ÆÒµ¥¹ÍÀº µðÁöÅÐ Çコ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ºÒ·¯ÀÏÀ¸Ä×°í, ¿ø°Ý ¸ð´ÏÅ͸µ, ÀçȰ, Á¤½Å°Ç°­À» À§ÇÑ ´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºíÀÇ Ã¤ÅÃÀ» ÃËÁøÇß½À´Ï´Ù. ·Ï´Ù¿î ±â°£ µ¿¾È ½ºÆ®·¹½º¿Í ½Å°æÇÐÀû °Ç°­¿¡ ´ëÇÑ ¿ì·Á°¡ Ä¿Áö¸é¼­ ¼ÒºñÀÚµéÀÇ °ü½ÉÀÌ ´õ¿í ³ô¾ÆÁ³½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀº ºü¸£°Ô ¿ø°ÝÀÇ·á ¸ðµ¨·Î ÀüȯÇϰí ÀÖÀ¸¸ç, ȯÀÚ Ä¡·áÀÇ ÀÏȯÀ¸·Î ¿þ¾î·¯ºí ¼Ö·ç¼ÇÀ» ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, COVID-19´Â ´º·ÎÀÎŬ·ç½Ãºê ±â¼úÀÇ Àå±âÀûÀÎ ¼ö¿ë°ú ÅëÇÕÀ» °¡¼ÓÈ­Çß½À´Ï´Ù.

EEG Çìµå¼Â ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

EEG Çìµå¼Â ºÎ¹®Àº ½Å°æÇÐÀû ¸ð´ÏÅ͸µ, ÀÎÁö ¿¬±¸, º¸Á¶ Ä¿¹Â´ÏÄÉÀÌ¼Ç ±â¼ú¿¡¼­ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµÇ¸é¼­ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ÀåÄ¡´Â ºñħ½ÀÀû ³úÆÄ ÃßÀûÀ» °¡´ÉÇÏ°Ô ÇÏ¿© ½Å°æ Àå¾Ö ȯÀÚ³ª ¸í»ó, ½ºÆ®·¹½º °ü¸®¿Í °°Àº À£´Ï½º¿¡ ƯȭµÈ ¾ÖÇø®ÄÉÀ̼ǿ¡ ÇʼöÀûÀÔ´Ï´Ù. ¼ÒÇüÈ­µÈ Àü±Ø°ú ¹«¼± ¿¬°áÀÇ ¹ßÀü¿¡ ÈûÀÔ¾î EEG Çìµå¼ÂÀº Á¡Á¡ ´õ »ç¿ëÇϱ⠽¬¿öÁö°í ÀÖÀ¸¸ç, ÇコÄɾî, ÀçȰ ¹× ¼ÒºñÀÚ À£ºù »ýŰ迡¼­ ¿ìÀ§¸¦ Á¡Çϰí ÀÖ½À´Ï´Ù.

°ü¼º ¹× »ý¸®Àû ¼¾¼­ À¶ÇÕ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È °ü¼º ¼¾¼­ ¹× »ý¸®Àû ¼¾¼­ À¶ÇÕ ºÎ¹®ÀÌ °¡Àå ³ôÀº ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °¡¼Óµµ°è, ÀÚÀ̷νºÄÚÇÁ, ½É¹Ú¼ö ¸ð´ÏÅÍ, ÇǺΠ¼¾¼­ÀÇ µ¥ÀÌÅ͸¦ ÅëÇÕÇÏ¿© ÀÌ ¿þ¾î·¯ºíÀº Á¾ÇÕÀûÀÎ ½Å°æ»ý¸®ÇÐÀû Çǵå¹éÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ À¶ÇÕ ±â¼úÀº ½ºÆ÷Ã÷, ÀçȰ, Á¤½Å°Ç°­ ¾ÖÇø®ÄÉÀ̼ÇÀÇ ½Ç½Ã°£ ¸ð´ÏÅ͸µÀ» °­È­ÇÕ´Ï´Ù. °³ÀÎÈ­µÈ °Ç°­ ¹× ¼º´É ÃÖÀûÈ­¸¦ À§ÇÑ ¸ÖƼ¸ð´Þ µ¥ÀÌÅÍ ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó, ¸ÖƼ¸ð´Þ µ¥ÀÌÅÍ ºÐ¼®ÀÇ ºü¸¥ º¸±Þ°ú ¼ºÀåÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

ÃÖ´ë Á¡À¯À² Áö¿ª

¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀº µðÁöÅÐ ÇコÄɾ ´ëÇÑ Á¤ºÎÀÇ °­·ÂÇÑ ÀÌ´Ï¼ÅÆ¼ºê, ±Þ¼ÓÇÑ µµ½ÃÈ­, ½Å°æ ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ÀÎÇØ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß±¹, ÀϺ», Çѱ¹°ú °°Àº ±¹°¡µéÀº ¿þ¾î·¯ºí ¿¬±¸°³¹ßÀ» ÃßÁøÇÏ´Â ÇÑÆí, ÇÏÀÌÅ×Å© ½ºÅ¸Æ®¾÷°ú ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ ÆÄÆ®³Ê½ÊÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å°æÇÐÀû °Ç°­¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡¿Í ÀÇ·á ÀÎÇÁ¶óÀÇ È®´ë°¡ äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¹æ´ëÇÑ Àα¸ ±â¹Ý°ú °¡ÀüÁ¦Ç°ÀÇ Á¶±â µµÀÔÀ¸·Î ÀÎÇØ ¾ÐµµÀûÀÎ ¼öÀÍ¿øÀÌ µÇ°í ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì°¡ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ´Âµ¥, ÀÌ´Â °­·ÂÇÑ Çõ½Å »ýŰè, Áö¿øÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, ³ôÀº ¼ÒºñÀÚ ¼Òºñ ¿©·Â¿¡ ±âÀÎÇÕ´Ï´Ù. ¹Ì±¹Àº ¿þ¾î·¯ºí ¿¬±¸ÀÇ ¼±±¸ÀÚÀÎ ´º·ÎÅ×Å©³î·¯Áö ½ºÅ¸Æ®¾÷°ú ´ëÇÐÀÇ º»°ÅÁöÀÔ´Ï´Ù. Á¤½Å°Ç°­ »óÅÂÀÇ À¯º´·ü Áõ°¡¿Í ÷´Ü Ä¡·á Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó äÅÃÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å°æÀ» Æ÷°ýÇÏ´Â ¿þ¾î·¯ºíÀÌ º¸ÇèÀ» ÅëÇØ ÇコÄɾî Ç÷£¿¡ ÅëÇյǰí ÀÖ´Â °Íµµ ¼ºÀåÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ªµ¿ÀûÀΠȯ°æÀ¸·Î ÀÎÇØ ºÏ¹Ì´Â °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ª ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

¹«·á Ä¿½ºÅ͸¶ÀÌ¡ ¼­ºñ½º

º» º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù:

  • ±â¾÷ ¼Ò°³
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤, ¿¹Ãø, CAGR(ÁÖ : Ÿ´ç¼º °ËÅä¿¡ µû¸¥)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù¹ý
  • Á¶»ç ÀÚ·á
    • 1Â÷ Á¶»ç ÀÚ·á
    • 2Â÷ Á¶»ç Á¤º¸ Ãâó
    • °¡Á¤

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ±â¼ú ºÐ¼®
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºí ½ÃÀå : µð¹ÙÀ̽º À¯Çüº°

  • EEG Çìµå¼Â
  • ÀÎÀ̾îÇü ´º·Î ¼¾½Ì µð¹ÙÀ̽º
  • ´º·ÎÇǵå¹é ´ëÀÀ ÇìµåÆù
  • ½º¸¶Æ® ±Û·¡½º
  • ½º¸¶Æ® Çï¸ä

Á¦6Àå ¼¼°èÀÇ ´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºí ½ÃÀå : ÅëÇÕ ¸ðµåº°

  • µ¶¸³Çü ¼ÒºñÀÚ¿ë µð¹ÙÀ̽º
  • ±â¾÷/ÀÓ»ó µî±Þ ½Ã½ºÅÛ
  • ÀÓº£µðµå OEM ¸ðµâ

Á¦7Àå ¼¼°èÀÇ ´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºí ½ÃÀå : ±â¼úº°

  • ³úÆÄ(EEG) ¼¾¼­
  • ±â´ÉÀû ±ÙÀû¿Ü¼± ºÐ±¤¹ý(fNIRS)
  • °ü¼º ¼¾¼­¡¤»ý¸®ÇÐÀû ¼¾¼­ À¶ÇÕ

Á¦8Àå ¼¼°èÀÇ ´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºí ½ÃÀå : ¿ëµµº°

  • ÁýÁß·Â Æ®·¹ÀÌ´×
  • Å×¶óÇÇ ¼­Æ÷Æ®
  • ÇÇ·Î °ü¸®
  • ½Å°æÀçȰ
  • ÈÞ¸Õ ¸Ó½Å ÀÎÅÍ·¢¼Ç

Á¦9Àå ¼¼°èÀÇ ´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºí ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼ÒºñÀÚ
  • ÇコÄÉ¾î ±â°ü¡¤Å¬¸®´Ð
  • ±â¾÷
  • ±º¡¤¹æÀ§
  • ¿¬±¸±â°ü ¹× Çмú±â°ü

Á¦10Àå ¼¼°èÀÇ ´º·ÎÀÎŬ·ç½Ãºê ¿þ¾î·¯ºí ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ °³¿ä

  • Emotiv Inc.
  • Neurable Inc.
  • Kernel
  • NextMind(Snap Inc.)
  • Muse(InteraXon Inc.)
  • MindMaze SA
  • Cognixion
  • Bitbrain Technologies
  • NeuroSky Inc.
  • OpenBCI
  • BioSemi
  • Brain Products GmbH
  • Compumedics Neuroscan
  • ANT Neuro
  • g.tec medical engineering GmbH
  • Neuroelectrics
  • Luxonis
  • iMotions A/S
KSM 25.09.30

According to Stratistics MRC, the Global Neuro-Inclusive Wearables Market is accounted for $1.5 billion in 2025 and is expected to reach $4.2 billion by 2032 growing at a CAGR of 16% during the forecast period. Neuro-Inclusive Wearables are digital devices designed to support cognitive, sensory, and neurological needs of users by monitoring brain activity, stress levels, and neural signals. These wearables incorporate technologies like electroencephalography (EEG), biosensors, and artificial intelligence for real-time insights into brain health. They aim to enhance inclusivity by addressing conditions such as autism, ADHD, and mental health challenges. Neuro-inclusive wearables are used in healthcare, wellness, and assistive technology domains for personalized support.

According to the World Health Organization (WHO), with over 1 billion people living with a neurological disorder, there is growing investment in wearable technology designed to support conditions like ADHD, autism, and anxiety.

Market Dynamics:

Driver:

Advancements in brain-computer interface tech

The Neuro-Inclusive Wearables market is driven by rapid advancements in brain-computer interface (BCI) technologies that enhance accessibility and cognitive assistance. These innovations enable individuals with neurological conditions to interact seamlessly with digital platforms, improving independence and quality of life. Fueled by breakthroughs in neural signal decoding and non-invasive sensors, BCI-driven wearables are gaining adoption across healthcare and assistive applications. Moreover, expanding research partnerships between universities and tech firms accelerate commercialization, firmly positioning BCI innovations as a key growth catalyst.

Restraint:

Complex regulatory approval processes

A significant restraint in the Neuro-Inclusive Wearables market is the complexity of regulatory approval processes for medical-grade devices. Strict requirements from agencies such as the FDA and EMA extend development timelines, elevating compliance costs for manufacturers. These rigorous standards are essential for safety but hinder smaller innovators from entering the market. Additionally, variations in approval protocols across regions complicate global commercialization strategies. As a result, lengthy regulatory pathways act as a bottleneck, slowing product launches and restraining market expansion.

Opportunity:

Growth in remote patient monitoring solutions

Expanding demand for remote patient monitoring creates promising opportunities for neuro-inclusive wearable adoption. Healthcare providers increasingly deploy wearables to monitor brain activity, detect stress, and track rehabilitation progress outside clinical environments. Spurred by rising incidences of neurological disorders and the push for personalized care, remote monitoring enhances patient outcomes while reducing hospital visits. Integration with telemedicine platforms further amplifies growth potential. As digital healthcare ecosystems evolve, wearables tailored for neurological inclusivity are set to play a central role in connected health solutions.

Threat:

Data security and privacy challenges

The Neuro-Inclusive Wearables market faces threats from escalating data security and privacy concerns. Wearables capture sensitive neurological and physiological data, making them prime targets for cyberattacks. Breaches not only compromise patient trust but also expose vendors to stringent penalties under data protection regulations such as GDPR and HIPAA. Growing consumer awareness about digital vulnerabilities intensifies hesitation toward adoption. Without robust encryption, anonymization, and compliance frameworks, security risks threaten to erode confidence and impede the widespread integration of neuro-inclusive wearables globally.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the Neuro-Inclusive Wearables market. Initially, supply chain disruptions and delayed clinical trials slowed product rollouts. However, the pandemic spurred demand for digital health solutions, driving adoption of neuro-inclusive wearables for remote monitoring, rehabilitation, and mental wellness. Increased stress and neurological health concerns during lockdowns further boosted consumer interest. Healthcare systems rapidly pivoted to telehealth models, embedding wearable solutions as part of patient care. Consequently, COVID-19 accelerated long-term acceptance and integration of neuro-inclusive technologies.

The EEG headsets segment is expected to be the largest during the forecast period

The EEG headsets segment is expected to account for the largest market share during the forecast period, owing to their extensive use in neurological monitoring, cognitive research, and assistive communication technologies. These devices enable non-invasive brainwave tracking, making them vital for patients with neurological disorders and for wellness-focused applications like meditation and stress management. Fueled by advancements in miniaturized electrodes and wireless connectivity, EEG headsets are becoming increasingly user-friendly, supporting their dominance across healthcare, rehabilitation, and consumer wellness ecosystems.

The Inertial & Physiological Sensor Fusion segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the inertial & physiological sensor fusion segment is predicted to witness the highest growth rate, impelled by its ability to combine motion tracking with biometric insights for enhanced accuracy. By integrating data from accelerometers, gyroscopes, heart-rate monitors, and skin sensors, these wearables deliver comprehensive neuro-physiological feedback. This fusion technology enhances real-time monitoring for sports, rehabilitation, and mental health applications. Rising demand for multimodal data analysis in personalized health and performance optimization fuels its rapid adoption, driving accelerated growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by strong government initiatives in digital healthcare, rapid urbanization, and rising investments in neurotechnology. Countries like China, Japan, and South Korea are advancing wearable R&D while fostering partnerships between tech startups and healthcare providers. Additionally, growing awareness of neurological health and expanding healthcare infrastructure support adoption. The region's massive population base and early adoption of consumer electronics position Asia Pacific as the dominant revenue generator.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, attributed to strong innovation ecosystems, supportive regulatory frameworks, and high consumer spending power. The U.S. is home to leading neurotechnology startups and universities pioneering wearable research. Increased prevalence of mental health conditions and demand for advanced therapeutic devices further amplify adoption. Moreover, growing integration of neuro-inclusive wearables into insurance-backed healthcare plans accelerates growth. This dynamic environment positions North America as the fastest-expanding regional market.

Key players in the market

Some of the key players in Neuro-Inclusive Wearables Market include Emotiv Inc., Neurable Inc., Kernel, NextMind (Snap Inc.), Muse (InteraXon Inc.), MindMaze SA, Cognixion, Bitbrain Technologies, NeuroSky Inc., OpenBCI, BioSemi, Brain Products GmbH, Compumedics Neuroscan, ANT Neuro, g.tec medical engineering GmbH, Neuroelectrics, Luxonis, and iMotions A/S.

Key Developments:

In July 2025, Neurable Inc. announced a partnership with Meta to integrate its dry-electrode EEG analytics platform into the next-generation Meta Quest Pro headset, focusing on cognitive load monitoring for productivity and wellness applications.

In June 2025, Kernel launched its next-generation, wearable "Kernel Flow" headset with improved ergonomics and a 50% reduction in size, making continuous, high-fidelity hemodynamic brain recording feasible for clinical and research use outside the lab.

In May 2025, Muse (InteraXon Inc.) introduced the "Muse S2," a sleek, headband-style wearable that provides real-time neurofeedback for meditation and now includes features for tracking focus and managing ADHD symptoms throughout the workday.

Device Types Covered:

  • EEG Headsets
  • In-Ear Neuro-Sensing Devices
  • Neurofeedback-Enabled Headphones
  • Smart Glasses
  • Smart Helmets

Integration Modes Covered:

  • Standalone Consumer Devices
  • Enterprise / Clinical-Grade Systems
  • Embedded OEM Modules

Technologies Covered:

  • Electroencephalography (EEG) Sensors
  • Functional Near-Infrared Spectroscopy (fNIRS)
  • Inertial & Physiological Sensor Fusion

Applications Covered:

  • Focus Training
  • Therapy Support
  • Fatigue Management
  • Neurorehabilitation
  • Human-Machine Interaction

End Users Covered:

  • Consumers
  • Healthcare Providers & Clinics
  • Enterprises
  • Military & Defense
  • Research Institutions & Academia

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.1 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neuro-Inclusive Wearables Market, By Device Type

  • 5.1 Introduction
  • 5.2 EEG Headsets
  • 5.3 In-Ear Neuro-Sensing Devices
  • 5.4 Neurofeedback-Enabled Headphones
  • 5.5 Smart Glasses
  • 5.6 Smart Helmets

6 Global Neuro-Inclusive Wearables Market, By Integration Mode

  • 7.1 Introduction
  • 7.2 Standalone Consumer Devices
  • 7.3 Enterprise / Clinical-Grade Systems
  • 7.4 Embedded OEM Modules

7 Global Neuro-Inclusive Wearables Market, By Technology

  • 7.1 Introduction
  • 7.2 Electroencephalography (EEG) Sensors
  • 7.3 Functional Near-Infrared Spectroscopy (fNIRS)
  • 7.4 Inertial & Physiological Sensor Fusion

8 Global Neuro-Inclusive Wearables Market, By Application

  • 8.1 Introduction
  • 8.2 Focus Training
  • 8.3 Therapy Support
  • 8.4 Fatigue Management
  • 8.5 Neurorehabilitation
  • 8.6 Human-Machine Interaction

9 Global Neuro-Inclusive Wearables Market, By End User

  • 9.1 Introduction
  • 9.2 Consumers
  • 9.3 Healthcare Providers & Clinics
  • 9.4 Enterprises
  • 9.5 Military & Defense
  • 9.6 Research Institutions & Academia

10 Global Neuro-Inclusive Wearables Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Emotiv Inc.
  • 12.2 Neurable Inc.
  • 12.3 Kernel
  • 12.4 NextMind (Snap Inc.)
  • 12.5 Muse (InteraXon Inc.)
  • 12.6 MindMaze SA
  • 12.7 Cognixion
  • 12.8 Bitbrain Technologies
  • 12.9 NeuroSky Inc.
  • 12.10 OpenBCI
  • 12.11 BioSemi
  • 12.12 Brain Products GmbH
  • 12.13 Compumedics Neuroscan
  • 12.14 ANT Neuro
  • 12.15 g.tec medical engineering GmbH
  • 12.16 Neuroelectrics
  • 12.17 Luxonis
  • 12.18 iMotions A/S
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦